Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intellia Therapeutics Inc buy BMO Capital Markets

Intellia Therapeutics Inc
Start price
€22.58
10.11.23 / 50%
Target price
€58.01
10.11.24
Performance (%)
-2.97%
Price
€21.91
03.05.24
Summary
This prediction is currently active. With a performance of -2.97%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. This prediction currently runs until 10.11.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Intellia Therapeutics Inc 13.026% 13.026%
iShares Core DAX® -0.922% -1.993%
iShares Nasdaq 100 0.371% -0.868%
iShares Nikkei 225® 2.224% -5.187%
iShares S&P 500 -0.026% -0.918%

Comments by BMO_Capital_Markets for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -2.97%
Target price 58.007
Change
Ends at 10.11.24

Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at BMO Capital Markets from $64.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat

BMO Capital Markets 
0
Report Share
10.11.23

Stopped prediction by BMO_Capital_Markets for Intellia Therapeutics Inc

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€36.37
13.03.23
-
13.03.24
-27.88%
14.03.24

BMO Capital Markets 
13.03.23 50%